公开(公告)号：EP2156879A3

公开(公告)日：2010-07-07

申请号：EP09012086.6

申请日：2002-10-10

申请人： Aviva Biosciences Corporation

发明人： Yamanishi, Douglas ,  Hujsak, Paul ,  Yang, Zhaohuai ,  Xu, Junquan ,  Wang, Xiaobo ,  Wu, Lei ,  Huang, Mingxian ,  Tao, Guoliang ,  Cheng, Jing

IPC分类号： B01D57/02

CPC分类号： G01N15/05 ,  A61M1/36 ,  A61M1/3618 ,  A61M1/362 ,  A61M1/3679 ,  G01N1/40 ,  G01N15/0272 ,  G01N33/491 ,  G01N2015/0288 ,  G01N2015/0294 ,  G01N2015/0681

摘要： The present invention recognizes that diagnosis and prognosis of many conditions can depend on the enrichment of rare cells from complex fluid sample. In particular, the enrichment of fetal cells from maternal samples, such as maternal blood samples, can greatly aid in the detection of fetal abnormalities or a variety of genetic conditions. In addition, the present invention recognizes that the enrichment of rare malignant cells for patient samples can in diagnosis, prognosis, and development of therapeutic modalities for patients.

摘要翻译： 本发明认识到许多病症的诊断和预后可以取决于来自复杂液体样品的稀有细胞的富集。 具体而言，母体样本（如母体血液样本）富集胎儿细胞可以极大地帮助检测胎儿异常或各种遗传病症。 另外，本发明认识到，用于患者样品的稀有恶性细胞的富集可以用于患者的诊断，预后和发展治疗模式。

公开(公告)号：EP2156879A2

公开(公告)日：2010-02-24

申请号：EP09012086.6

申请日：2002-10-10

申请人： Aviva Biosciences Corporation

发明人： Yamanishi, Douglas ,  Hujsak, Paul ,  Yang, Zhaohuai ,  Xu, Junquan ,  Wang, Xiaobo ,  Wu, Lei ,  Huang, Mingxian ,  Tao, Guoliang ,  Cheng, Jing

IPC分类号： B01D57/02

CPC分类号： G01N15/05 ,  A61M1/36 ,  A61M1/3618 ,  A61M1/362 ,  A61M1/3679 ,  G01N1/40 ,  G01N15/0272 ,  G01N33/491 ,  G01N2015/0288 ,  G01N2015/0294 ,  G01N2015/0681

摘要： The present invention recognizes that diagnosis and prognosis of many conditions can depend on the enrichment of rare cells from complex fluid sample. In particular, the enrichment of fetal cells from maternal samples, such as maternal blood samples, can greatly aid in the detection of fetal abnormalities or a variety of genetic conditions. In addition, the present invention recognizes that the enrichment of rare malignant cells for patient samples can in diagnosis, prognosis, and development of therapeutic modalities for patients.

摘要翻译： 本发明认识到并的许多条件的诊断和预后可以取决于从复杂流体样品稀有细胞的富集。 特别是，胎儿细胞从母体样品，颜色的富集：如母体血液样品中，可以在检测胎儿畸形或多种遗传条件极大地帮助。 此外，本发明认识到确实少见恶性细胞的富集的患者样品可以在诊断，预后和为患者治疗方法的发展。